Change over period: —
NSE · AMRUTANJAN
AMRUTANJAN
-28.3% from the 52-week high · +5.9% above the low
Amrutanjan Health Care Ltd. engages in the manufacture and sale of ayurvedic and allopathic products. The company is headquartered in Chennai, Tamil Nadu and currently employs 647 full-time employees. The company went IPO on 2009-11-05. Its segments include OTC Products, Beverages and Others. The OTC Products segment is engaged in manufacturing products of pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. Its pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. Its beverages include Fruitnik and Fruitnik Electro+. The company also has other products category.
The short version. Promoter holding was 46.52% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
AMRUTANJAN trades 28.3% below its 52-week high and 5.9% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Up 1.17 pts over 8 quarters.
Down 4.22 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.52 | 46.52 | 46.52 | 46.52 | 46.52 | 46.52 | 46.52 | 46.52 | 0.0 |
| FII | 2.3 | 2.3 | 2.41 | 2.38 | 2.27 | 2.17 | 2.44 | 3.47 | +1.17 |
| DII | 11.12 | 11.41 | 12.7 | 12.9 | 13.0 | 12.66 | 12.28 | 6.9 | -4.22 |
| Public | 40.02 | 39.74 | 38.33 | 38.16 | 38.18 | 38.61 | 38.72 | 43.08 | +3.06 |
Mutual fund holdings · Oct 2026
7 schemes hold this stock
7 the month before.
- ICICI Prudential FMCG Fund2.16% of NAV
- ICICI Prudential Quant Fund1.39% of NAV
- ICICI Prudential Balanced Hybrid Fund1.2% of NAV
- ICICI Prudential Conservative Hybrid Fund0.1% of NAV
- Motilal Oswal BSE Healthcare ETF0.05% of NAV
- Bandhan BSE Healthcare Index Fund0.05% of NAV
- DSP Small Cap Fund0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for AMRUTANJAN are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about AMRUTANJAN
What is the AMRUTANJAN share price?
AMRUTANJAN (AMRUTANJAN) last closed at ₹514.40, down 0.39% on the day. Its 52-week range is ₹487.65 to ₹719.85.
What is the market cap of AMRUTANJAN?
AMRUTANJAN has a market capitalisation of about ₹1,492 crore. Its price-to-earnings ratio is 25.9.
How are AMRUTANJAN's latest results?
Promoter holding was 46.52% in Sep 2026, up 0.00 points over 8 quarters.
Who owns AMRUTANJAN?
As of Sep 2026, shareholding was: Promoter 46.52%, FII 3.47%, DII 6.9%, Public 43.08%.
How many mutual funds hold AMRUTANJAN?
7 mutual fund schemes held AMRUTANJAN in October 2026. That compares with 7 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 06 Feb 2026 · Interim Dividend - Rs. 1
- 18 Nov 2025 · Interim Dividend - Rs. 1
- 16 Sep 2025 · Final Dividend - Rs. 2.6
- 18 Feb 2025 · Interim Dividend - Rs. 1
- 22 Nov 2024 · Interim Dividend - Rs. 1
- 13 Sep 2024 · Final Dividend - Rs. 2.6
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.